| 000 | 01615nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025947.0 | ||
| 008 | 091108s2009 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.15.M.Sc.2009.As.F | ||
| 100 | 0 | _aAsmaa Osaman Abdelazeem | |
| 245 | 1 | 0 |
_aFetus at risk in pre-eclamptic patient / _cAsmaa Osaman Abdelazeem ; Supervised Asmaa Farid Abddasy , Magdy ibrahim Mostafa , Nadine Alaa Sherif |
| 246 | 1 | 5 | _aالاخطار التى يتعرض لها الجنين فى مريضة تسمم الحمل |
| 260 |
_aCairo : _bAsmaa Osaman Abdelazeemb , _c2009 |
||
| 300 |
_a99Leaves : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
| 520 | _aPreeclampsia is a disease affecting pregnant women after 20 weeks of gestation characterized by hypertension and proteinuria . Preeclampsia remains a leading cause of maternal and fetal mortality and morbidity while research in this important area of reproductive disease remains sporadic and grossly undefended | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aFetal impact | |
| 653 | 4 | _aIntrauterine growth restriction | |
| 653 | 4 | _aPreeclampsia | |
| 700 | 0 |
_aAsmaa Farid Abddasy , _eSupervisor |
|
| 700 | 0 |
_aMagdy ibrahim Mostafa , _eSupervisor |
|
| 700 | 0 |
_aNadine Alaa Sherif , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24404 _d24404 |
||